Leena Nahata
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leena Nahata has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Laurie E. Cohen
Boston Children’s Hospital, Boston, MA, USA
3 shared publicationsRichard N. Yu
Boston Children’s Hospital, Boston, MA, USA
3 shared publicationsDepartment of Pediatric Oncology
Background: Pediatric medulloblastoma patients have high survival rates and are at risk for treatment-related sequelae, including infertility, emphasizing the need for fertility counseling. This cohort is less likely to pursue higher education, marry, and live independently, which may impact fertility counseling. Our goal was to explore fertility-related concerns in medulloblastoma survivors and counseling practices among providers
1 shared publicationDepartment of Urology
Division of Hematology/Oncology, Department of Medicine, Boston Children's Hospital
1 shared publicationDivision of Endocrinology
Department of Urology, Department of Medicine, Boston Children's Hospital
1 shared publicationDivision of Hematology/Oncology
Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
1 shared publication
Latest Publications
- Open Access
- 1 December 2013
- Published by Taylor & Francis in Clinical Oncology in Adolescents and Young Adults
- Vol. 3, 89-94
Fertility in male medulloblastoma survivors: closing the gaps in counseling
Fertility in male medulloblastoma survivors: closing the gaps in counseling Leena Nahata,1 Richard N Yu,2 Ian P Dumont,3,4 Peter E Manley,3,4 Laurie E Cohen1,3,4 1Division of Endocrinology, 2Department of Urology, Department of Medicine, Boston Children's Hospital, 3Division of Hematology/Oncology, Department of Medicine, Boston Children's Hospital, 4Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Background: Pediatric medulloblastoma patients have high survival rates and are at risk for treatment-related sequelae, including infertility, emphasizing the need for fertility counseling. This cohort is less likely to pursue higher education, marry, and live independently, which may impact fertility counseling. Our goal was to explore fertility-related concerns in medulloblastoma survivors and counseling practices among providers. Methods: This study was performed at the Dana-Farber/Children's Hospital Cancer Center in Boston, Massachusetts. Surveys were administered to male pediatric medulloblastoma survivors aged 18 years and older and pediatric neuro-oncology practitioners. Medical records were reviewed to determine treatment protocols and documentation of fertility counseling. Data analysis was descriptive. Results: Fourteen male medulloblastoma survivors and six neuro-oncology practitioners completed the study. All patients had received central nervous system irradiation and adjuvant chemotherapy with at least one alkylating agent. Five (83%) practitioners stated that they discussed fertility with all survivors at most visits. Eight (57%) medulloblastoma survivors stated that they had received fertility counseling at initial diagnosis. Six (43%) stated that fertility had been discussed since treatment had ended. The majority (>70%) of survivors reported a desire to have children and were open to learning more about their fertility status. Fertility counseling was documented in survivorship visits in only 46% of subjects. Conclusion: Most of our subjects had no documented fertility-related discussions after completing treatment and could not recall any fertility counseling during survivorship; the majority wished to learn more about their fertility status. This suggests that the frequency with which practitioners initiate these discussions may be inadequate. Keywords: infertility, fertility counseling, medulloblastoma, survivorship
- 1 December 2013
- Published by Taylor & Francis in Clinical Oncology in Adolescents and Young Adults
- Vol. 3, 89-94
Open AccessFertility in male medulloblastoma survivors: closing the gaps in counseling
Fertility in male medulloblastoma survivors: closing the gaps in counseling Leena Nahata,1 Richard N Yu,2 Ian P Dumont,3,4 Peter E Manley,3,4 Laurie E Cohen1,3,4 1Division of Endocrinology, 2Department of Urology, Department of Medicine, Boston Children's Hospital, 3Division of Hematology/Oncology, Department of Medicine, Boston Children's Hospital, 4Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA Background: Pediatric medulloblastoma patients have high survival rates and are at risk for treatment-related sequelae, including infertility, emphasizing the need for fertility counseling. This cohort is less likely to pursue higher education, marry, and live independently, which may impact fertility counseling. Our goal was to explore fertility-related concerns in medulloblastoma survivors and counseling practices among providers. Methods: This study was performed at the Dana-Farber/Children's Hospital Cancer Center in Boston, Massachusetts. Surveys were administered to male pediatric medulloblastoma survivors aged 18 years and older and pediatric neuro-oncology practitioners. Medical records were reviewed to determine treatment protocols and documentation of fertility counseling. Data analysis was descriptive. Results: Fourteen male medulloblastoma survivors and six neuro-oncology practitioners completed the study. All patients had received central nervous system irradiation and adjuvant chemotherapy with at least one alkylating agent. Five (83%) practitioners stated that they discussed fertility with all survivors at most visits. Eight (57%) medulloblastoma survivors stated that they had received fertility counseling at initial diagnosis. Six (43%) stated that fertility had been discussed since treatment had ended. The majority (>70%) of survivors reported a desire to have children and were open to learning more about their fertility status. Fertility counseling was documented in survivorship visits in only 46% of subjects. Conclusion: Most of our subjects had no documented fertility-related discussions after completing treatment and could not recall any fertility counseling during survivorship; the majority wished to learn more about their fertility status. This suggests that the frequency with which practitioners initiate these discussions may be inadequate. Keywords: infertility, fertility counseling, medulloblastoma, survivorship
- 8 July 2013
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 52 (10) , 936-941
Klinefelter Syndrome
Klinefelter syndrome is a common condition that remains underdiagnosed, particularly prior to adulthood. Early detection could prevent morbidity and mortality, but the classic phenotype of small testes and tall stature may not be apparent until adolescence, and there is minimal guidance regarding whom to screen. We performed a retrospective study at Boston Children’s Hospital in patients with the ICD-9 code for “Klinefelter syndrome” diagnosed prior to age 20 years, and determined age and reason for diagnosis, karyotype, heights, and comorbid conditions. Eighty percent had a 47,XXY karyotype, of whom half were diagnosed at age 11 to 19 years. The most common comorbidities were neurocognitive, including learning disabilities (67%), psychosocial problems (33%), and attention deficit disorder (27%). Subjects were only slightly taller than average in childhood (height standard deviation score = 0.64). These data show that Klinefelter syndrome is associated with long-standing comorbidities that frequently remain under-recognized; a karyotype should be considered in boys with neurocognitive problems.
- 8 July 2013
- Published by SAGE Publications in Clinical Pediatrics
- Vol. 52 (10) , 936-941
Klinefelter Syndrome
Klinefelter syndrome is a common condition that remains underdiagnosed, particularly prior to adulthood. Early detection could prevent morbidity and mortality, but the classic phenotype of small testes and tall stature may not be apparent until adolescence, and there is minimal guidance regarding whom to screen. We performed a retrospective study at Boston Children’s Hospital in patients with the ICD-9 code for “Klinefelter syndrome” diagnosed prior to age 20 years, and determined age and reason for diagnosis, karyotype, heights, and comorbid conditions. Eighty percent had a 47,XXY karyotype, of whom half were diagnosed at age 11 to 19 years. The most common comorbidities were neurocognitive, including learning disabilities (67%), psychosocial problems (33%), and attention deficit disorder (27%). Subjects were only slightly taller than average in childhood (height standard deviation score = 0.64). These data show that Klinefelter syndrome is associated with long-standing comorbidities that frequently remain under-recognized; a karyotype should be considered in boys with neurocognitive problems.
- 3 May 2012
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (1) , 129-132
Semen analysis in adolescent cancer patients prior to bone marrow transplantation: When is it too late for fertility preservation?
Background: Sperm banking is an effective method of fertility preservation in adolescent boys with cancer but is strikingly underutilized, partly due to inconsistencies in fertility counseling and unclear guidelines regarding who should bank sperm. Patients undergoing bone marrow transplantation (BMT) are of particular interest given the high risk of infertility in this population.Procedure: We reviewed the charts of male cancer patients who underwent BMT at age ≥13 years at the Dana‐Farber Cancer Institute (DFCI) from 2003 to 2010 to determine the number of fertility preservation attempts prior to initial treatment and/or BMT, and the outcomes of those sperm banking attempts.Results: Sixty‐eight male cancer patients who had a BMT at age ≥13 years at the DFCI from 2003 to 2010 were included in the analysis. Six patients had attempted sperm banking prior to initial therapy. Thirty‐three patients attempted to bank prior to BMT; of those, 39% were azoospermic and 15% were oligospermic. Nineteen patients did not attempt to bank, and in 13 patients the decision to bank was unclear.Conclusions: A more consistent approach to fertility counseling is essential for adolescent cancer patients. Though first line therapy may be low‐risk in terms of long‐term impact on fertility, our results demonstrate that transient gonadal dysfunction is common and ongoing chemotherapy may affect spermatogenesis. Should a patient undergo BMT during this period, sperm banking is unlikely to be successful; initial fertility risk assessment should account for this possibility. Pediatr Blood Cancer 2013; 60: 129–132.
- 3 May 2012
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 60 (1) , 129-132
Semen analysis in adolescent cancer patients prior to bone marrow transplantation: When is it too late for fertility preservation?
Background: Sperm banking is an effective method of fertility preservation in adolescent boys with cancer but is strikingly underutilized, partly due to inconsistencies in fertility counseling and unclear guidelines regarding who should bank sperm. Patients undergoing bone marrow transplantation (BMT) are of particular interest given the high risk of infertility in this population.Procedure: We reviewed the charts of male cancer patients who underwent BMT at age ≥13 years at the Dana‐Farber Cancer Institute (DFCI) from 2003 to 2010 to determine the number of fertility preservation attempts prior to initial treatment and/or BMT, and the outcomes of those sperm banking attempts.Results: Sixty‐eight male cancer patients who had a BMT at age ≥13 years at the DFCI from 2003 to 2010 were included in the analysis. Six patients had attempted sperm banking prior to initial therapy. Thirty‐three patients attempted to bank prior to BMT; of those, 39% were azoospermic and 15% were oligospermic. Nineteen patients did not attempt to bank, and in 13 patients the decision to bank was unclear.Conclusions: A more consistent approach to fertility counseling is essential for adolescent cancer patients. Though first line therapy may be low‐risk in terms of long‐term impact on fertility, our results demonstrate that transient gonadal dysfunction is common and ongoing chemotherapy may affect spermatogenesis. Should a patient undergo BMT during this period, sperm banking is unlikely to be successful; initial fertility risk assessment should account for this possibility. Pediatr Blood Cancer 2013; 60: 129–132.